• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reporting Considerations for Cefepime-Susceptible and -Susceptible-Dose Dependent Results for Carbapenemase-Producing .碳青霉烯酶产生菌对头孢吡肟敏感及剂量依赖性敏感结果的报告注意事项
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.01271-20.
2
In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).亚太地区 INFORM 项目（2015-2017 年）收集的革兰氏阴性细菌分离株的头孢他啶-阿维巴坦和对照药物的体外活性。
Ann Clin Microbiol Antimicrob. 2020 Apr 1;19(1):14. doi: 10.1186/s12941-020-00355-1.
3
Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae.临床和实验室标准协会（CLSI）及欧洲抗菌药物敏感性试验委员会（EUCAST）头孢吡肟折点变化对肠杆菌科细菌药敏报告的影响
Diagn Microbiol Infect Dis. 2017 Dec;89(4):328-333. doi: 10.1016/j.diagmicrobio.2017.08.020. Epub 2017 Oct 12.
4
Detection of carbapenemase-producing Enterobacterales and the BD Phoenix CPO Detect panel.检测产碳青霉烯酶肠杆菌科和 BD Phoenix CPO Detect 检测板。
Expert Rev Mol Diagn. 2019 Aug;19(8):659-665. doi: 10.1080/14737159.2019.1645598. Epub 2019 Aug 1.
5
Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.南非肠杆菌科细菌中抗菌药物敏感性试验对碳青霉烯酶基因存在情况的预测
BMC Infect Dis. 2016 Oct 4;16(1):536. doi: 10.1186/s12879-016-1858-7.
6
Comparison of phenotypic tests for detecting BKC-1-producing Enterobacteriaceae isolates.检测产BKC-1肠杆菌科分离株的表型试验比较。
Diagn Microbiol Infect Dis. 2016 Mar;84(3):246-8. doi: 10.1016/j.diagmicrobio.2015.11.021. Epub 2015 Nov 27.
7
Improved Accuracy of Cefepime Susceptibility Testing for Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae with an On-Demand Digital Dispensing Method.采用按需数字分配法提高对产超广谱β-内酰胺酶肠杆菌科细菌头孢吡肟药敏试验的准确性
J Clin Microbiol. 2017 Feb;55(2):470-478. doi: 10.1128/JCM.02128-16. Epub 2016 Nov 30.
8
Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.使用更新的临床和实验室标准协会解释标准，对携带扩展型β-内酰胺酶的肠杆菌科对扩展型头孢菌素的敏感性模式。
Int J Antimicrob Agents. 2013 Apr;41(4):383-7. doi: 10.1016/j.ijantimicag.2012.12.003. Epub 2013 Feb 1.
9
Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?产碳青霉烯酶肠杆菌科细菌的药敏折点：问题解决了吗？
Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:33-40. doi: 10.1016/S0213-005X(14)70172-7.
10
Meropenem-Vaborbactam Activity against Carbapenem-Resistant Isolates Collected in U.S. Hospitals during 2016 to 2018.美罗培南-法硼巴坦对 2016 年至 2018 年期间美国医院分离的碳青霉烯类耐药菌株的活性。
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01951-19.

引用本文的文献

1
Laboratory detection of carbapenemases among Gram-negative organisms.革兰氏阴性菌中碳青霉烯酶的实验室检测
Clin Microbiol Rev. 2024 Dec 10;37(4):e0005422. doi: 10.1128/cmr.00054-22. Epub 2024 Nov 15.
2
Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant Enterobacterales.比较 BD Phoenix 与纸片扩散法和肉汤微量稀释法检测耐碳青霉烯类肠杆菌科细菌的头孢吡肟药敏结果。
J Clin Microbiol. 2024 Jun 12;62(6):e0152023. doi: 10.1128/jcm.01520-23. Epub 2024 May 7.

本文引用的文献

1
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.儿童碳青霉烯类耐药肠杆菌科感染的治疗。
J Pediatric Infect Dis Soc. 2020 Feb 28;9(1):56-66. doi: 10.1093/jpids/piz085.
2
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.碳青霉烯类耐药革兰氏阴性菌感染的治疗选择。
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S565-S575. doi: 10.1093/cid/ciz830.
3
Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.注意：如果依赖于肠杆菌科的历史折点来解释碳青霉烯类和头孢菌素类药物的药敏试验，可能会导致结果解读不一致，并且可能会漏检耐碳青霉烯类的病原体。
Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):187-195. doi: 10.1007/s10096-019-03711-y. Epub 2019 Nov 2.
4
Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.理解和应对 CLSI 折点修订：临床实验室的入门指南。
J Clin Microbiol. 2019 May 24;57(6). doi: 10.1128/JCM.00203-19. Print 2019 Jun.
5
Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.在不同最低抑菌浓度下接受优化剂量头孢吡肟治疗的革兰氏阴性感染患者的临床结局
J Pharm Pract. 2018 Feb;31(1):34-39. doi: 10.1177/0897190017696950. Epub 2017 Mar 6.
6
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.新型和重新出现的旧药物在治疗耐碳青霉烯类肠杆菌科细菌感染中的作用。
Virulence. 2017 May 19;8(4):403-416. doi: 10.1080/21505594.2016.1207834. Epub 2016 Jul 6.
7
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.治疗耐碳青霉烯类肺炎克雷伯菌血流感染的联合治疗方案
Antimicrob Agents Chemother. 2016 May 23;60(6):3601-7. doi: 10.1128/AAC.03007-15. Print 2016 Jun.
8
Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.确定与改善生存相关的革兰氏阴性血流感染中头孢吡肟的临床暴露情况。
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1401-10. doi: 10.1128/AAC.01956-15.
9
Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection.头孢吡肟联合阿莫西林/克拉维酸：产KPC肺炎克雷伯菌感染的新选择。
Int J Infect Dis. 2015 Sep;38:108-14. doi: 10.1016/j.ijid.2015.07.024. Epub 2015 Aug 6.
10
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.碳青霉烯类耐药肠杆菌科感染的治疗选择。
Open Forum Infect Dis. 2015 May 5;2(2):ofv050. doi: 10.1093/ofid/ofv050. eCollection 2015 Apr.

Reporting Considerations for Cefepime-Susceptible and -Susceptible-Dose Dependent Results for Carbapenemase-Producing .

作者信息

Fissel J A, Yarbrough M L, Tekle T, Burnham C A, Simner P J

机构信息

Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Department of Pathology & Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.

出版信息

J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.01271-20.

DOI:10.1128/JCM.01271-20
PMID:32641398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7448622/
Abstract
摘要